Evidence map›Paper›PMID 38827288›Full record

ArticlePeerJ2024

Exploring

Yingkui Liu, Xinxin Fu, Yu Wang, Jing Liu, Yong Liu, Chong Li, Jiajia Dong

Abstract read
In one paragraph

Article in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yingkui LiuJiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry & Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.ORCID 0000-0002-0729-1408
Xinxin FuJiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry & Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
Yu WangJiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry & Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
Jing LiuJiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry & Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
Yong LiuJiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry & Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
Chong LiJiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry & Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
Jiajia DongJiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry & Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.

Funding

Natural Science Foundation of ChinaNatural Science Foundation of Jiangsu ProvinceNatural Science Foundation of the Higher Education Institutions of Jiangsu Province, ChinaScience and Technology Project of Xuzhou
6 · The paper itself

Abstract

Background: Methods: Next-generation sequencing (NGS) was used to simultaneously capture the entire mitochondrial genome and the full-length 18S/28S rDNA sequences. The species boundary of Results: The full lengths of the mitochondrial genome, 18S and 28S rDNAs of

Indexed as

PhylogenyAnimalsGenome, MitochondrialHigh-Throughput Nucleotide SequencingLeechesRNA, Ribosomal, 28SRNA, Ribosomal, 28SbGMYCbPTPLeechesMitochondrial genomePhylogenetic treerDNASpecies delimitation

Identifiers

PMID38827288
PMCPMC11144392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.